PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,501 | +12.5% | 402 | +14.9% | 0.00% | – |
| Q1 2024 | $10,227 | -9.6% | 350 | 0.0% | 0.00% | – |
| Q4 2023 | $11,316 | +12.8% | 350 | 0.0% | 0.00% | -100.0% |
| Q3 2023 | $10,031 | -28.5% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $14,025 | -10.9% | 350 | -4.1% | 0.00% | 0.0% |
| Q1 2023 | $15,739 | +16.5% | 365 | +4.3% | 0.00% | 0.0% |
| Q4 2022 | $13,514 | -28.9% | 350 | -4.6% | 0.00% | 0.0% |
| Q3 2022 | $19,000 | -9.5% | 367 | +1.1% | 0.00% | -50.0% |
| Q2 2022 | $21,000 | 0.0% | 363 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $21,000 | +5.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $20,000 | -4.8% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $21,000 | -16.0% | 350 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $25,000 | +19.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $21,000 | 0.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $21,000 | +16.7% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | +50.0% | 350 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $12,000 | -25.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | +23.1% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | -13.3% | 350 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $15,000 | +15.4% | 350 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | -13.3% | 350 | 0.0% | 0.00% | -25.0% |
| Q4 2018 | $15,000 | -11.8% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $17,000 | +54.5% | 350 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $11,000 | 0.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | -31.2% | 350 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $16,000 | +23.1% | 350 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $13,000 | -23.5% | 350 | 0.0% | 0.01% | -37.5% |
| Q2 2017 | $17,000 | +6.2% | 350 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $16,000 | +45.5% | 350 | 0.0% | 0.01% | +28.6% |
| Q4 2016 | $11,000 | – | 350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |